Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company focuses on the treatment solutions for the management of liver disease, heart failure, malignant ascites, and other fluid imbalance disorders. It offers alfapump, an implantable, programmable, wirelessly-charged, battery-powered system that manages refractory ascites and malignant ascites. The company was founded by Noel L. Johnson in 2006 and is headquartered in Ghent, Belgium.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Sequana medical NV?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sequana medical NV market cap is $73.69M.
What is the 52-week high for Sequana medical NV?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sequana medical NV 52 week high is $3.00 as of October 01, 2025.
What is the 52-week low for Sequana medical NV?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sequana medical NV 52 week low is $0.78 as of October 01, 2025.
What is Sequana medical NV stock price today?
Sequana medical NV stock price today is $1.22.
What was Sequana medical NV stock price yesterday?
Sequana medical NV stock price yesterday was $1.22.
What is the PE ratio of Sequana medical NV?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Sequana medical NV’s P/E ratio is -0.92.
What is the Price-to-Book ratio of Sequana medical NV?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Sequana medical NV P/B ratio is -1.1797.
What is the 50-day moving average of Sequana medical NV?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Sequana medical NV 50-day moving average is $0.9032.
